Aponermin: First Approval
S Dhillon - Drugs, 2024 - Springer
Abstract Aponermin (沙艾特) is a recombinant circularly permuted human tumour necrosis
factor-related apoptosis-inducing ligand (TRAIL) developed by Beijing Sunbio Biotech (a …
factor-related apoptosis-inducing ligand (TRAIL) developed by Beijing Sunbio Biotech (a …
[HTML][HTML] GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells
L Booth, JL Roberts, C West, P Dent - Oncotarget, 2024 - ncbi.nlm.nih.gov
GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells
Purpose The goal of this study was to characterize the relationship between ATR and STAT3
interactions in human multiple myeloma (MM) cells. Methods Various MM cell lines …
interactions in human multiple myeloma (MM) cells. Methods Various MM cell lines …